Rucci Carolyn M.
SEC CIK 2107264 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | SVP, CLO | 588.4K | — | $97.0K | 2 | 2026-01-30 | 2026-02-02 |
Most active insiders at AKBA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Butler John P. | CEO, Pres, Dir | $86.6K | $474.4K |
| 2 | Grund Nicholas | Chief Commercial Off | — | $117.9K |
| 3 | Ostrowski Erik | SVP, CFO, CBO, Treas | — | $110.8K |
| 4 | Rucci Carolyn M. | SVP, CLO | — | $97.0K |
| 5 | Burke Steven Keith | SVP, Chief Medical Off | — | $94.0K |
| 6 | Malabre Richard C | SVP, CAO | — | $68.8K |
| 7 | FRIESON RON | Dir | — | — |
| 8 | Wolf Myles | Dir | — | — |
| 9 | Smith Cynthia | Dir | — | — |
| 10 | ADAMS ADRIAN | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-02-04 | 2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Rucci Carolyn M. | SVP, CLO | S - Sale | $1.39 | -69.8K | 588.4K | -11% | -$97.0K |
| D | 2026-02-03 | 2026-01-30 | AKBA | Akebia Therapeutics, Inc. | Rucci Carolyn M. | SVP, CLO | A - Grant | $0.00 | +190.0K | 658.1K | +41% | $0 |
Purchase Sale Sale after option exercise All abbreviations